Health TrialsbyHealthPanel

Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge

ConditionsOsteoporosis RiskOsteoporosis, Postmenopausal
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age50+
SponsorSingHealth Polyclinics

About this trial

This is a pilot randomised controlled trial (RCT) to evaluate the use of a Virtual Health Assistant (VHA) named Osteo-Buddy in improving the knowledge of osteoporosis in older women.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 50 and above

Medium or high Osteoporosis Self-Assessment Tool for Asians (OSTA) score

Not undertaken Bone Mineral Density (BMD) scan

Never been treated with anti-osteoporosis medications such as bisphosphonates (e.g. alendronate, risendronate, ibandronate, zolendronate, pamidronate) or denosumab

Disqualifiers

Known terminal illness

Visual, hearing and/or cognitive impairment or mental illness that renders them unable to provide informed consent

Trial design

Design model

Parallel

Treatments tested in this trial

  • Osteo-Buddy

    Other intervention

    Osteo-Buddy is a Virtual Health Assistant (VHA) accessible on mobile phones that helps users with: 1. Evaluating their risk level of osteoporosis 2. Recommending screening and referrals 3. Lifestyle interventions through motivation, education and tailored guidance As a 24/7 VHA, it offers real-time, personalised advice based on user inputs and health data.

  • Usual Care

    Other intervention

    Access to digitalised educational materials on osteoporosis, titled 'Healthy Bones'

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: InterventionExperimental treatment 2 interventions
Group B: ControlExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Osteoporosis Prevention and Awareness Tool (OPAAT) score

* 30-item questionnaire measuring osteoporosis knowledge * Minimum value = 0, maximum value = 30 * Higher scores indicate a better outcome

Time frame
On enrolment and 6-8 weeks post enrolment
2

System Usability Scale (SUS)

* 10-item questionnaire assessing usability * Minimum value = 0, maximum value = 100 * Higher scores mean a better outcome

Time frame
6-8 weeks post enrolment

Secondary outcomes

1

Recruitment rate

Percentage of participants successfully recruited among referred participants

Time frame
over the course of recruitment, estimated 3-4 months
2

Retention rate

Percentage of recruited participants who complete the study (return for 2nd visit and successfully complete 2nd questionnaire)

Time frame
6-8 weeks post-enrolment
3

Utility rate

Percentage of intervention arm participants who utilise Osteo-Buddy over the 4 weeks

Time frame
4 weeks

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

SingHealth Polyclinics

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: